These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3157433)

  • 1. Potentiation of beta-endorphin effects by cholecystokinin antiserum in rats.
    Itoh S; Katsuura G; Yoshikawa K; Rehfeld JF
    Can J Physiol Pharmacol; 1985 Jan; 63(1):81-3. PubMed ID: 3157433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of beta-endorphin effects by proglumide in rats.
    Katsuura G; Itoh S
    Eur J Pharmacol; 1985 Jan; 107(3):363-6. PubMed ID: 3156751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive effect of cholecystokinin and its related peptides on beta-endorphin-induced catalepsy in rats.
    Itoh S; Katsuura G
    Eur J Pharmacol; 1981 Sep; 74(4):381-4. PubMed ID: 6271561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caerulein and cholecystokinin suppress beta-endorphin-induced analgesia in the rat.
    Itoh S; Katsuura G; Maeda Y
    Eur J Pharmacol; 1982 Jun; 80(4):421-5. PubMed ID: 6286327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarities of the cataleptic state induced by beta-endorphin and morphine.
    Rondeau DB; Turcotte M; Young L; Hebert D
    Pharmacol Biochem Behav; 1982 Oct; 17(4):703-7. PubMed ID: 6294679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of beta-endorphin, thyrotropin-releasing hormone and cholecystokinin on body shaking behavior in rats.
    Itoh S; Katsuura G
    Jpn J Physiol; 1982; 32(4):667-75. PubMed ID: 6294391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fronto-cortical regulation of beta-endorphin actions in the rat.
    Itoh S; Katsuura G
    Peptides; 1985; 6(2):237-40. PubMed ID: 3162160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of cholecystokinin and its related peptides in rats.
    Itoh S; Katsuura G
    Prog Clin Biol Res; 1985; 192():139-45. PubMed ID: 2934743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tolerance to the pharmacological effects of human beta-endorphin by prolyl-leucyl-glycinamide and cyclo(leucylglycine) in the rat.
    Bhargava HN
    J Pharmacol Exp Ther; 1981 Aug; 218(2):404-8. PubMed ID: 6114170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylmethylsulfonyl fluoride (PMSF) given systemically produces naloxone-reversible analgesia and potentiates effects of beta-endorphin given centrally.
    Pinsky C; Dua AK; LaBella FS
    Life Sci; 1982 Sep 20-27; 31(12-13):1193-6. PubMed ID: 6292607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Endorphin controls vasopressin release during foot shock-induced stress in the rat.
    Knepel W; Nutto D; Anhut H
    Regul Pept; 1983 Sep; 7(1):9-19. PubMed ID: 6316422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Endorphin: central sites of analgesia, catalepsy and body temperature changes in rats.
    Tseng LF; Wei ET; Loh HH; Li CH
    J Pharmacol Exp Ther; 1980 Aug; 214(2):328-32. PubMed ID: 6248633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of cholecystokinin, beta-endorphin, and their antagonists on passive avoidance behavior in rats.
    Itoh S; Katsuura G; Takashima A
    Can J Physiol Pharmacol; 1987 Nov; 65(11):2260-4. PubMed ID: 2966663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebroventricular cholecystokinin infusions block beta-endorphin-induced disruption of maternal behavior.
    Felicio LF; Mann PE; Bridges RS
    Pharmacol Biochem Behav; 1991 May; 39(1):201-4. PubMed ID: 1924504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prolonged analgesic effect of an antiserum to beta-endorphin in rats].
    Litvinov SV; Aristova VV; Aristov IuA; Shul'govskiĭ VV; Kaliuzhnyĭ LV
    Patol Fiziol Eksp Ter; 1989; (5):50-2. PubMed ID: 2533346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective effect of beta-endorphin on the production of analgesia and the spinal release of met-enkephalin in rats.
    Tseng LF
    J Pharmacol Exp Ther; 1986 Oct; 239(1):160-5. PubMed ID: 3020229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro effects of cholecystokinin octapeptide on the release of beta-endorphin-like immunoreactivity.
    Matsumura M; Yamanoi A; Yamamoto S; Saito S
    Neuroendocrinology; 1983 Jun; 36(6):443-8. PubMed ID: 6308491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that spinal endorphin mediates intraventricular beta-endorphin-induced tail flick inhibition and catalepsy.
    Tseng LF; Fujimoto JM
    Brain Res; 1984 Jun; 302(2):231-7. PubMed ID: 6329457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of immunoreactive [Met5]enkephalin and cholecystokinin from the spinal cord by beta-endorphin administered intraventricularly in the pentobarbital-anesthetized rat.
    Tseng LF; Huang FY
    Eur J Pharmacol; 1992 May; 215(2-3):309-12. PubMed ID: 1396996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence for beta-endorphin involvement in the long-lasting antagonistic effect of caerulein on amphetamine hyperactivity in rats.
    Matsubara K
    Eur J Pharmacol; 1986 Feb; 121(2):297-301. PubMed ID: 2938979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.